Indian Journal of Pharmaceutical Education and Research logo
Article

Formulation and Characterization of Tapentadol Loaded Emulgel for Topical Application

1, 1, 1, 1

  1. 1Department of Pharmaceutics, KLE University College of Pharmacy, Belagavi-590010, Karnataka, INDIA.

CORRESPONDENCE

Nitin Prabhakar Ambhore

Department of Pharmaceutics, KLE University College of Pharmacy, Belagavi-590010, Karnataka, INDIA.

nitinpatil.ambhore@gmail.com

Received: 15-01-2017; Accepted: 30-03-2017.

Volume 51, Issue 4 · pp. 525-534 · 2017 · DOI: 10.5530/ijper.51.4.81

ABSTRACT

Background: Tapentadol is a centrally acting analgesic drug which falls under class III drug as per biopharmaceutical classification systems having poor bioavailability.Aim: Therefore, present study was aimed at solubility and permeability enhancement of Tapentadol using emulsomes loaded emulgel drug delivery system.Methods: Emulgel was prepared using data light liquid paraffin, Tween 20 and PEG 400 as Surfactant and Co-surfactant respectively. For preparation of stable Emulgel, micro emulsion region was identified by constructing pseudo ternary phase diagram containing different proportion of surfactant: co-surfactant (1:1, 2:1 and 3:1), oil and water. Ex vivo drug release study was done and compared to in vitro drug release of optimized formulation X2Q1. Physico- Chemical Evaluation: Total nine Emulgel formulations were prepared and evaluated for self-emulsification time, dispersibility, droplet size analysis, stability studies, turbidimetry, zeta potential, drug content and in vitro and ex vivo drug release.Results: Among all the formulations, optimized formulation X2Q1 with 1.5% carbopol 981 and optimized Q1 emulsion formulation showed in vitro drug release of 90.03 % at the end of 8 hrs. Based on results of self-emulsification time & dispersibility, droplet size analysis, drug content and in vitro drug release the X2Q1 formulation was selected as an optimized formulation which showed a maximum drug release in vitro and ex vivo and extended drug release up to eight hrs. The optimized formulation found to be stable, non-irritant and safe for topical drug delivery.Conclusion: Hence emulgel formulations can be a potential alternative to traditional oral drug delivery systems of Tapentadol to improve its bioavailability.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Ambhore, N. P., Dandagi, P. M., Gadad, A. P., & Mandora, P. (2017). Formulation and Characterization of Tapentadol Loaded Emulgel for Topical Application. Indian Journal of Pharmaceutical Education and Research, 51(4), 525-534. https://doi.org/10.5530/ijper.51.4.81

    Copyright and licence

    © 2017 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0